Joseph Truluck - 23 May 2023 Form 4 Insider Report for ADIAL PHARMACEUTICALS, INC. (ADIL)

Role
Chief Financial Officer
Signature
/s/ Joseph Truluck
Issuer symbol
ADIL
Transactions as of
23 May 2023
Net transactions value
$0
Form type
4
Filing time
25 May 2023, 16:50:18 UTC
Previous filing
25 Feb 2022
Next filing
27 Mar 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ADIL Common Stock Award $0 +157,500 +146% $0.000000 265,139 23 May 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ADIL Stock Option (Right to Buy) Award $0 +125,000 $0.000000 125,000 23 May 2023 Common Stock 125,000 $0.3025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests pro rata on a monthly basis over 36 months commencing May 23, 2023.